The Effectiveness of Telerehabilitation in Stroke Patients

This study is a randomized controlled study. The patients will be randomly divided into two groups as exercise and control. Patients in both groups will be given lower-upper extremity exercises and gait training exercises selected according to the Bobath approach as a home program consisting of 10 exercises to be applied 5 days a week for 3 weeks. All patients will perform the same exercises. In addition, the exercise group will receive Modified-Constraint Induced Movement Therapy (m-CIMT) based telerehabilitation via video conferencing 5 days a week for 3 weeks. Patients in the m-CIMT group will be asked to restrict the movements of their less affected hands by using mitt for 5 hours a day/ 5 days a week for 3 weeks while the patients are awake. Evaluations for both groups will be made by a physiotherapist blinded to the study twice, at the beginning and 3 weeks later. As outcome measures functional performance, hand strength, activities of daily living and quality of life will be evaluated.

Inclusion criteria

• 18-65 years of age
• Being diagnosed with stroke for the first time by a doctor
• Having been diagnosed with stroke at least 1 month ago
• Mini-Mental Test Score more than or equal 24
• In the upper extremities; Starting from the angle of full flexion, wrist extension of at least 20° or more, thumb extension or abduction of at least 10°, minimum extension of all other fingers at the metacarpophalangeal and interphalangeal joints
• Having less than 2.5 points in the pre-treatment evaluation from both parts of MAG-28
• Being able to stand for 2 minutes without any help by using the upper extremity as a support tool when necessary.
• Absence of severe pain to affect the treatment
• Absence of severe spasticity to affect the treatment (spasticity in any joint of the upper extremity ≤ 2 according to the Modified Ashworth Scale)

Exclusion criteria

• Any orthopedic, vision, hearing or perception problems that may affect the research results
• Having an additional neurological, cardiovascular, pulmonary or hormonal disorder that would prevent participation in the study.